These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28948854)

  • 1. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
    Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
    J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
    McCluskie MJ; Deschatelets L; Krishnan L
    Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
    Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
    Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
    Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
    Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
    PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
    González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
    J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes.
    Sprott GD; Brisson J; Dicaire CJ; Pelletier AK; Deschatelets LA; Krishnan L; Patel GB
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):275-88. PubMed ID: 10521711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of archaeosome adjuvants evaluated in a mouse model.
    Patel GB; Omri A; Deschatelets L; Sprott GD
    J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Archaeosome immunostimulatory vaccine delivery system.
    Patel GB; Chen W
    Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
    Akache B; Jia Y; Chandan V; Deschatelets L; McCluskie MJ
    Methods Mol Biol; 2022; 2412():255-267. PubMed ID: 34918249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
    Krishnan L; Dennis Sprott G;
    J Drug Target; 2003; 11(8-10):515-24. PubMed ID: 15203920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
    Jia Y; Chandan V; Akache B; Qian H; Jakubek ZJ; Vinogradov E; Dudani R; Harrison BA; Jamshidi MP; Stark FC; Deschatelets L; Sauvageau J; Williams D; Krishnan L; McCluskie MJ
    J Liposome Res; 2021 Sep; 31(3):237-245. PubMed ID: 32583693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
    Akache B; Agbayani G; Stark FC; Jia Y; Dudani R; Harrison BA; Deschatelets L; Chandan V; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model.
    Jia Y; Akache B; Agbayani G; Chandan V; Dudani R; Harrison BA; Deschatelets L; Hemraz UD; Lam E; Régnier S; Stark FC; Krishnan L; McCluskie MJ
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.
    Benvegnu T; Lemiègre L; Cammas-Marion S
    Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):206-20. PubMed ID: 19534669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
    Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
    Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archaeosomes and Gas Vesicles as Tools for Vaccine Development.
    Adamiak N; Krawczyk KT; Locht C; Kowalewicz-Kulbat M
    Front Immunol; 2021; 12():746235. PubMed ID: 34567012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.